Prof. Theo Kanellos

Theo Kanellos qualified as a veterinarian from the Aristotle University of Thessaloniki in Greece and has been awarded an MSc in microbiology and PhD in molecular medicine from the University of London.

He also has a business diploma from the Ecole Supérieur de Commerce de Paris (ESCP).

During his career he worked as a clinician, an academic, a governmental official and for the last fifteen years as part of the management within the Pharmaceutical Industry where he has held several strategic roles.

He has managed research laboratories, business development transactions, scientific and multi-functional alliances teams and programmes in several organisations that have led to the spinoff of biotechnology companies, the award of significant scientific grants, the founding of major strategic partnerships and the registration and licensing of successful commercial products and services.

Ιn Zoetis he established business transactions and entrepreneurial partnerships with companies, venture capitalists groups, universities, and governmental institutions, internationally.

He holds a visiting professorship at the School of Health and Medicine at the University of Surrey and he is a board member in several organisations including the Pirbright Institute in UK, the Global Alliance for Livestock Veterinary Medicines in Africa, The Global Antimicrobial Research Innovation Fund, Action group of the One Health Platform etc.

In his current role, he holds the position of Group Innovation and Corporate Alliances Director, CEVA, France.

He is the author of more than 30 peered reviewed papers and has given numerous presentations in several national and international conferences. His articles and interviews have also featured in many trade and public media.